TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 502 participants.

Also called NCT01134393

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 502 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01134393
  • EudraCT 2009-017336-40
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Results first posted
(from the registry)
Countries
Germany, Italy, Mexico, Netherlands, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01134393. Non-randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-05 (actual). Results posted on 2012-07-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
Condition
Hypertension
Intervention (Drug)
telmisartan/amlodipine
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct01134393
Content hash
3081bf4c810996e9c7de2bdc215ba825af729202b4aa6573ca3a985fe700902e